A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer Subjects With the Overexpression of HER2

Optimization of Preoperative Treatment in Locally Advanced Rectal Cancer

NCT02533271 ·Status: UNKNOWN ·Phase: PHASE3

Total Neoadjuvant Treatment vs. Chemoradiotherapy in Local Advanced Rectal Cancer With High Risk Factors

NCT03177382 ·Status: UNKNOWN ·Phase: PHASE3

A Study of Total Neoadjuvant Therapy for High-risk Locally Advanced Rectal Cancer

NCT04543695 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study of Treatment Patterns in HER2-positive Unresectable and Advanced Gastric/ Gastroesophageal Junction Cancer in China

NCT06585501 ·Status: COMPLETED

Extent of Lymph Node Dissection for Advanced Right-Sided Colon Cance

NCT06986538 ·Status: NOT_YET_RECRUITING ·Phase: NA

Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid Tumors

NCT05538195 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Validate the Dosimetric Parameters That Correlate With Acute Hematologic Toxicity (HT) in Patients With Rectal Cancer

NCT02630056 ·Status: UNKNOWN

Neoadjuvant Arterial Embolization Chemotherapy Combined PD-1 Inhibitor for Locally Advanced Rectal Cancer

NCT05420584 ·Status: RECRUITING ·Phase: PHASE2

Rectal Artery Infusion Chemotherapy Combined With Anti-PD1 Antibody for MSS LARC

NCT05307198 ·Status: UNKNOWN ·Phase: PHASE2

Chemotherapy Combined With High-dose Radiotherapy for Low Rectal Cancer Using MR Guided Linear Accelerator

NCT05338866 ·Status: ENROLLING_BY_INVITATION

Neoadjuvant Chemoradiation With Nal-IRI and Capecitabine Guided by UGT1A1 Status in Patients With Rectal Cancer

NCT06210971 ·Status: RECRUITING ·Phase: PHASE2

Genotype-driven Weekly Irinotecan Liposomes in Combination With Capecitabine-based Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer

NCT06300489 ·Status: RECRUITING ·Phase: PHASE1

Treatment of Rectal Cancer With Long-term Concurrent Chemoradiotherapy Combined With Camrelizumab

NCT06304545 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers

NCT04221893 ·Status: RECRUITING ·Phase: NA

The Efficacy of Primary Total Mesorectal Excision (TME) Surgery Versus Neoadjuvant Chemotherapy Combined With TME Surgery in Low-risk Locally Advanced Rectal Cancer

NCT05984485 ·Status: RECRUITING ·Phase: PHASE3

Neoadjuvant Short-course Radiotherapy Followed by the Combination of Immunotherapy and Chemotherapy in Locally Advanced Rectal Cancer

NCT04663763 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

UGT1A1-Based Irinotecan Therapy for Locally Advanced Rectal Cancer

NCT05148767 ·Status: RECRUITING ·Phase: PHASE4

A Prospective Phase II Study of Individualized Neoadjuvant Chemoradiotherapy for Rectal Cancer Based on Recurrence Risk

NCT04664504 ·Status: RECRUITING ·Phase: PHASE2

A Prospective Phase II Randomized Clinical Trial of Preoperative Chemotherapy Combined With Short-course Radiotherapy Versus Conventional Neo-adjuvant Therapy for Locally Advanced Rectal Cancer Implemented by MDT

NCT02941562 ·Status: UNKNOWN ·Phase: PHASE2

Preoperative Chemoradiotherapy With Raltitrexed for Intermediate or Locally Advanced Rectal Cancer in the Fit Elderly

NCT02992886 ·Status: COMPLETED ·Phase: PHASE2

Nodes-sparing Short-course Radiation Combined With CAPOX and Tislelizumab for MSS Middle and Low Rectal Cancer

NCT05972655 ·Status: RECRUITING ·Phase: PHASE2

Preoperative CRT With Capecitabine ± Temozolomide in Patients With LARC

NCT03156036 ·Status: COMPLETED ·Phase: PHASE2

The Effect of Bone Marrow-sparing Intensity-Modulated Radiotherapy to GI Cancer

NCT01863420 ·Status: UNKNOWN

Radiotherapy With Neoadjuvant Chemotherapy and Immunotherapy in Rectal Cancer

NCT04558684 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2

Comparing Preoperative Short-course Radiotherapy With or Without Local Boost for Rectal Cancer

NCT02498353 ·Status: UNKNOWN ·Phase: NA